₹-5.05
(Market cap
₹205 Cr
Recently Viewed
Clear AllMarket cap
₹205 Cr
Revenue (TTM)
₹90 Cr
P/E Ratio
28.7
P/B Ratio
3.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹7 Cr
ROE
13.7 %
ROCE
16.7 %
Industry P/E
44.38
EV/EBITDA
13.2
Debt to Equity
0
Book Value
₹59.4
EPS
₹6.8
Face value
10
Shares outstanding
10,513,450
CFO
₹11.16 Cr
EBITDA
₹43.30 Cr
Net Profit
₹17.78 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vaidya Sane Ayur
| -31.5 | -3.0 | -16.7 | 56.6 | -6.8 | -- | -- |
|
BSE Healthcare
| 1.8 | 4.5 | 5.7 | 4.6 | 24.6 | 13.6 | 11.0 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Vaidya Sane Ayur
| 109.1 | -36.9 | 17.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vaidya Sane Ayur
|
195.0 | 205.0 | 89.9 | 7.2 | -- | 13.7 | 28.7 | 3.3 |
| 5.5 | 6.6 | 0.5 | -0.1 | -89.9 | -- | -- | 0.5 | |
| 24.6 | 14.0 | 8.0 | 0.6 | 13.8 | 5.5 | 22.2 | 1.1 | |
| 661.8 | 8,222.5 | 469.1 | 90.7 | -- | 39 | 90.6 | 19.6 | |
| 238.6 | 310.1 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 62.1 | |
| 24.6 | 42.1 | 49.3 | 0.8 | 1.6 | 4.5 | 55.4 | 2.5 | |
| 43.6 | 42.2 | 67.2 | 2.1 | 3.3 | 4.9 | 20.6 | 1.2 | |
| 205.0 | 322.8 | 162.9 | 9.8 | -- | 32.2 | 32.9 | 6.3 | |
| 128.3 | 82.6 | 65.4 | 2.8 | 6.6 | 12.1 | 29.7 | 3.4 | |
| 38.0 | 35.7 | 71.8 | 2.8 | -- | 18.2 | 15.4 | 2.2 |
No Review & Analysis are available.
Manufacture of ayurvedic' or unani' pharmaceutical preparation
Incorporated
1999
Chairman
--
Managing Director
Rohit Madhav Sane
Headquarters
Pune, Maharashtra
Website
Looking for more details about Vaidya Sane Ayurved Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Vaidya Sane Ayurved Laboratories Ltd is ₹195.00 (NSE) as of 23-Apr-2026 IST. Vaidya Sane Ayurved Laboratories Ltd has given a return of -6.82% in the last 3 years.
The P/E ratio of Vaidya Sane Ayurved Laboratories Ltd is 28.73 times as on 23-Apr-2026, a 35 discount to its peers’ median range of 44.38 times.
The P/B ratio of Vaidya Sane Ayurved Laboratories Ltd is 3.28 times as on 23-Apr-2026, a 31 discount to its peers’ median range of 4.76 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.81
|
1.58
|
|
2024
|
92.39
|
4.34
|
|
2023
|
51.12
|
6.11
|
|
2022
|
59.10
|
5.71
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Vaidya Sane Ayurved Laboratories Ltd are Rs 335.00 and Rs 118.65 as of 23-Apr-2026.
Vaidya Sane Ayurved Laboratories Ltd has a market capitalisation of ₹ 205 Cr as on 23-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vaidya Sane Ayurved Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.